Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis-Reference-Cited by-同舟云学术

Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis

Published:2016-10-30 Issue:2 Volume:109 Page:djw217
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI J Natl Cancer Inst

Author:

Zhang Yaxiong,Yang Yunpeng,Zhang Zhonghan,Fang Wenfeng,Kang Shiyang,Luo Youli,Sheng Jin,Zhan Jianhua,Hong Shaodong,Huang Yan,Zhou Ningning,Zhao Hongyun,Zhang Li

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/109/2/djw217/17497413/djw217.pdf

Reference63 articles.

1. Nausea and vomiting as major complications of cancer chemotherapy;Laszlo;Drugs,1983

2. Management of Chemotherapy-Induced Nausea and Vomiting

3. Emerging treatments in chemotherapy-induced nausea and vomiting;Grunberg;Clin Adv Hematol Oncol.,2013

4. Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis;Frontiers in Oncology;2024-07-26

2. Impact of prophylactic dexamethasone on the efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy in patients with advanced Non-Squamous Non-Small-Cell lung cancer;International Immunopharmacology;2023-12

3. Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy;Journal of Oncology Pharmacy Practice;2023-08-10

4. The Role of Substance P Within Traumatic Brain Injury and Implications for Therapy;Journal of Neurotrauma;2023-08-01

5. Impact of Prophylactic Dexamethasone on the Efficacy of Immune Checkpoint Inhibitors Plus Platinum-based Chemotherapy in Patients with Advanced Non-Squamous Non-Small- Cell Lung Cancer;2023-05-09